bristol-myers squibb co (BMY:New York)
Beth C. Seidenberg M.D.
|Age||Total Calculated Compensation||This person is connected to 117 board members in 16 different organizations across 19 different industries.|
See Board Relationships
Dr. Beth C. Seidenberg, M.D., is a Partner, General Partner, and Investment Partner at Kleiner Perkins Caufield & Byers. Dr. Seidenberg is a part of the life sciences team investing in digital health and biotech. She works with entrepreneurs to develop companies with breakthrough technology to treat patients and improve health. She joined the KPCB in 2005 and has incubated five companies. She serves as the Chairman and Founder of NVCA-MedIC coalition focusing on FDA ...
345 Park AvenuePhone: 212-546-4000
New York, New York 10154
Board Members Memberships*
Former Independent Director, Chairman of Compensation Committee and Member of Corporate Governance & Nominating Committee
Independent Director, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
Director and Member of Audit Committee
Non-Employee Director and Chairman of Nominating & Corporate Governance Committee
University Of Miami School Of Medicine
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Robert A. Bradway||Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee|
|Robert J. Hugin MBA||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|John C. Lechleiter Ph.D.||Chairman, Chief Executive Officer and President|
Eli Lilly and Company
|Lars Rebien Sørensen||Chief Executive Officer and Member of Executive Management|
Novo Nordisk A/S
|Richard A. Gonzalez||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|$1.5M||Compensation as of Fiscal Year 2013.|